2013 annual financial data
Silence Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -5,774.36%.
Operating income was -9,072,000 GBP and net income was -9,002,000 GBP.
Operating cash flow was -6,756,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 117,000 GBP
- Operating income
- -9,072,000 GBP
- Net income
- -9,002,000 GBP
- Operating cash flow
- -6,756,000 GBP